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Abstract
Background: Non-communicable diseases (NCDs) are increasing in prevalence in low-income countries including
Uganda. The Uganda Ministry of Health has prioritized NCD prevention, early diagnosis, and management.
However, research on the capacity of public sector health facilities to address NCDs is limited.
Methods: We developed a survey guided by the literature and the standards of the World Health Organization
Pacakage of Essential Noncommunicable Disease Interventions for Primary Health Care in Low-Resource Settings.
We used this tool to conduct a needs assessment in 53 higher-level public sector facilities throughout Uganda,
including all Regional Referral Hospitals (RRH) and a purposive sample of General Hospitals (GH) and Health Centre
IVs (HCIV), to: (1) assess their capacity to detect and manage NCDs; (2) describe provider knowledge and practices
regarding the management of NCDs; and (3) identify areas in need of focused improvement. We collected data on
human resources, equipment, NCD screening and management, medicines, and laboratory tests. Descriptive
statistics were used to summarize our findings.
Results: We identified significant resource gaps at all sampled facilities. All facilities reported deficiencies in NCD
screening and management services. Less than half of all RRH and GH had an automated blood pressure machine.
The only laboratory test uniformly available at all surveyed facilities was random blood glucose. Sub-specialty NCD
clinics were available in some facilities with the most common type being a diabetes clinic present at eleven (85%)
RRHs. These facilities offered enhanced services to patients with diabetes. Surveyed facilities had limited use of NCD
patient registries and NCD management guidelines. Most facilities (46% RRH, 23% GH, 7% HCIV) did not track
patients with NCDs by using registries and only 4 (31%) RRHs, 4 (15%) GHs, and 1 (7%) HCIVs had access to
diabetes management guidelines.
Conclusions: Despite inter-facility variability, none of the facilities in our study met the WHO-PEN standards for
essential tools and medicines to implement effective NCD interventions. In Uganda, improvements in the allocation
of human resources and essential medicines and technologies, coupled with uptake in the use of quality assurance
modalities are desperately needed in order to adequately address the rapidly growing NCD burden.
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Background
Rapid population growth, urbanization, a nutritional
transition, and indoor and outdoor air pollution are
among the factors contributing to the growing burden
of the major global non-communicable diseases
(NCDs) in Uganda [1]. Based on a recent nationwide
representative survey, the prevalence of hypertension,
at 24.3%, approaches that in the United States [2].
The prevalence of diabetes mellitus is relatively low
in urban (2.7%) and in rural (1%) areas, although it is
expected to rise significantly in the near future [3].
Chronic obstructive pulmonary disease (COPD) in
rural Uganda, where the prevalence is 16.2%, appears
to be more common than in high-income countries
[4]. The epidemiology of cancers is shifting from a
predominance of HIV-associated malignancies to
those more typically associated with “Western life-
styles” [5].
Despite this burden of risk factors and associated
disease, as well as extensive experience in addressing
chronic HIV infection, the Ugandan healthcare system
remains ill-prepared to address NCDs [6]. Only a few
prior studies have evaluated the capacity of public sector
health facilties to provide NCD services. The Service
Availability and Readiness Assessment (SARA) is a World
Health Organization (WHO) -endorsed cross-sectional
survey that provides insight into overall health facility
readiness, though is limited in its acquisition of data spe-
cific to NCDs. To date, three SARA surveys have been
conducted in Uganda: 2012, 2013, and 2014 with the latter
being restricted to a sample of higher level facilties and
conducted after the present study was completed [7]. The
2013 Uganda SARA survey sampled 209 public and pri-
vate health facilities [8]. In that survey, the average avail-
ability of essential medicines to treat NCDs, across all
facilities, was only 15% and regression analyses identified
significant associations between availability of these medi-
cines and region, managing authority, facility type, and
HIV services [9]. Also, the tools necessary for the diagno-
sis and/or management of diabetes and cardiovascular dis-
ease were available in only 34 and 44% of facilities,
respectively. One geographically limited study of overall
readiness to manage chronic disease patients in the out-
patient units of urban and rural health facilities revealed
generally poor readiness to do so [10].
In 2006, in an effort to address the growing NCD
burden in the country, the Ugandan Ministry of Health
(MOH) created the Programme for the Prevention and
Control of NCDs. In a collaboration between that
Programme and the Uganda Initiative for Integrated
Management of Non-Communicable Diseases, we con-
ducted, in 2013, the first nationwide survey of public
sector Ugandan health facilities focused specifically on
readiness to provide services for NCDs. By doing so, we
were able to conduct a more detailed assessment of
NCD services than SARA surveys, which are intended
to assess a wide-ranging spectrum of health service
delivery readiness. We based our assessment of readiness
on the standards set forth by WHO Package of Es-
sential Noncommunicable Disease Interventions for
Primary Health Care in Low-Resource Settings
(WHO-PEN) [11].
Methods
Development of the needs assessment tool
We reviewed the published and grey literature to iden-
tify survey tools used in NCD-focused assessments con-
ducted in other LMIC [11, 12]. Two of this study’s
authors (HR and ARA) selected and adapted questions
to include based on their relevance to Uganda’s hospital
and facility structure and the MOH protocol for preven-
tion and treatment of NCDs. The specific diseases of
interest for this study were guided by official MOH prior-
ities and included: diabetes, cancer, cardiovascular disease,
chronic kidney disease, sickle cell disease, and COPD [13].
The medicines, technologies, and tools included in our
survey are based upon the standards of WHO-PEN
(Tables 1 and 2) [11]. Additional medicines, technologies,
tools, and guidelines deemed essential by MOH were also
included. The needs assessment tool was written collab-
oratively and was reviewed during a full-day meeting held
in Kampala in 2013 and attended by 30 stakeholder
groups including: MOH, Mulago National Referral Hos-
pital, Regional Referral Hospitals (RRH), WHO-Uganda,
and Uganda NCD Alliance (Appendix).
Sampling
Fifty-three public sector health facilities, including 14
Health Center IVs (HCIV), 26 General (District) Hospitals
(GH), and 13 Regional Referral Hospitals (RRH), were sur-
veyed (Appendix). These facility tiers were chosen because
they were expected to offer NCD services [13]. Character-
istics of each facility level have been previously published
[10]. In 2012, in the Ugandan public sector, there were 13
RRH, 116 GH, and 170 HCIV [14].
All RRHs were surveyed. Head administrators of each
RRH were asked to purposively select three GH or
HCIV within their catchment areas (38 facilities). The
selection criteria given to RRH staff included: equitable
geographical location within the RRH region; basic NCD
infrastructure already in place (clinics, equipment, and/
or services); and availability of some human resources
and basic infrastructure to implement service improve-
ment activities. Given that the survey was funded to sup-
port a total of 53 facilities, the final two facilities were
chosen randomly, for a total of 40 GH and HCIV.
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Data collection
Our study team, comprised of two authors (HR and
ARA) and two additional MOH employees, conducted
each assessment between July and November 2013. The
survey tool was divided into 13 sections. Up to three
members of the study team visited each facility and used
the survey questionnaire to interview personnel from
the facility department most relevant for each survey
section. One team member interviewed the appropriate
personnel while another team member manually entered
the intereviewee’s responses into the survey. At larger fa-
cilities, each team member simultaneously interviewed
personnel of different departments. These departments
included: the Director’s office, facility administration,
pharmacy, laboratory, outpatient clinics, and inpatient
wards. Spot-checking of equipment or medicines was
not formally incorporated into the survey.
Fifty-one surveys were completed by the study team
and facility staff during these visits. Weather and road
challenges prohibited the study team from visiting two
facilities (Kitgum and Bududa GH). For these, surveys
were completed by facility staff and sent back to MOH.
Gaps and inconsistencies were clarified, prior to analysis,
by way of follow-up calls to the relevant contacts in the
facilities. Despite these efforts, the response rate for
some survey variables was less than 100%. The denomi-
nators listed throughout the Results section of this paper
indicate the total number of facilities for which we have
data for each variable.
Analysis
All survey data were entered into a Microsoft Access 2013
database and all data analyses were conducted using SAS
(version 9.2). Data were analyzed according to the
organization of the original questionnaire (Additional file 1).
Descriptive statistics (N, % and Mean ± SD, where applic-
able) were calculated for each of the major categories of
services, equipment, pharmaceuticals, and laboratory ser-
vices for each facility type (RRH, GH, and HCIV). Such
analyses were deemed by MOH to be the most helpful for
identifying gaps and providing insight into where MOH
and funders’ resources are most needed across the RRHs,
GHs, and HCIVs.
Dissemination
The results of this needs assessment were compiled as a
Report and shared with the MOH NCD Unit in order to
guide the procurement and distribution of additional
health supplies.
Results
Description of sample
Thirteen RRH, 26 GH, and 14 HCIV were surveyed.
Eight of 9 (88.9%) RRH, 6/21 (28.6%) GH, and 3/12
(25%) HCIVs self-classified as urban (Table 3).
Health personnel
We have previously reported degrees of self-reported
confidence in NCD management among staff of various
cadres at the sampled facilities, as derived from other
sections of this survey [1]. In addition to those data, we
recorded the numbers of healthcare personnel relevant
to the care of patients with NCDs who were working at
each facility. As expected, since we only sampled higher
level facilities, the most common cadre of medical pro-
vider at all levels of facility sampled were Medical
Table 1 WHO essential technologies and tools for
implementing essential NCD interventions in primary care [11]
Technologies: Tools:
Thermometer
Stethoscope
Blood pressure measurement device
Measurement tape
Weighing machine
Peak flow meter
Spacers for inhalers
Glucometer
Blood glucose test strips
Urine protein test strips
Urine ketones test strips
WHO/ISH risk prediction
charts
Evidence based clinical
protocols
Flow charts with referral
criteria
Patient clinical record
Medical information
register
Audit tools
Add when resources permit
Nebulizer
Pulse oximeter
Blood cholesterol assay
Lipid profile
Serum creatinine assay
Troponin test strips
Urine microalbuminuria test strips
Tuning fork
Electrocardiograph (if training to read
and interpret electrocardiograms is
available)
Defibrillator
Table 2 WHO core list of medicines required for implementing
essential NCD interventions in primary care [11]
NCD Medicines
Thiazide diuretic
Calcium channel blocker (amlodipine)
Beta-blocker (atenolol)
Angiotensin inhibitor (enalapril)
Statin (simvastatin)
Insulin
Metformin
Glibenclamide
Isosorbide dinitrate
Glyceryl trinitrate
Furosemide
Spironolactone
Salbutamol
Prednisolone
Beclometasone
Aspirin
Paracetamol
Ibuprofen
Codeine
Morphine
Penicillin
Erythromycin
Amoxcillin
Hydrocortisone
Epinephrine
Heparin
Diazepam
Magnesium sulphate
Promethazine
Senna
Dextrose infusion
Glucose injectable solution
Sodium chloride infusion
Oxygen
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Officers (doctors who have completed an internship)
and Clinical Officers (non-medical doctor clinicians).
Specialist physicians and specialist nurses were rare at
the sampled facilities, with 6 (46.2%) RRH reporting at
least one radiologist but only 1 (7.7%) reporting a cardi-
ologist or an endocrinologist. Few facilities reported hav-
ing access to other cadres of health professionals
important in the ongoing care of patients with NCDs,
such as nutritionists, diabetes educators, who were on
staff at 1 (7.7%) RRH and 1 (3.8%) GH, or foot care spe-
cialists (Table 4).
Essential services and technologies
None of the sampled facilities reported having all of
the essential medical devices recommended by
WHO-PEN (Table 1). Less than half of all RRHs and
GHs had at least one of each type of blood pressure
machine (mercury sphygmomanometer, aneroid, an/or
automated). For facilities with non-physician health
workers, WHO recommends a blood pressure meas-
urement device with digital reading. Five out of the
14 HCIVs (35.7%) had at least one automated blood
pressure machine. Six (42.9%) had at least one aner-
oid machine and one mercury sphygmomanometer.
Few facilities reported having blood pressure cuffs: 4
(30.8%) RRHs, 9 (34.6%) GHs, and 8 (57.1%) HCIVs
reported having at least one standard adult cuff in
the facility and far less reported having a pediatric
cuff. Half of all types of health facilities (7 (53.8%)
RRHs, 13 (50%) GHs, and 7 (50%) HCIVs) had at
least one measuring tape which is used for anthropo-
metric measurements such as height and waist cir-
cumference. Of the facilities surveyed, 8 (61.5%)
RRHs, 19 (73.1%) GHs, and 6 (42.9%) HCIVs had at
least one glucometer. Three RRHs (23.1%), 2 GHs
(7.7%), and 2 HCIVs (14.3%) had urine testing strips
for protein and ketones (Table 5).
Advanced technologies
We collected data on the availability of advanced clinical
technologies, though these are not considered essential
and, therefore, are not included in WHO-PEN. More than
half of each type of health facility had an ultrasound scan,
but not all of them were functional at the time of the sur-
vey. For example, 11 (84.6%) RRHs had an ultrasound
scan, but only 6 (54.6%) of those were functional. Three
(23.1%) RRHs had an electrocardiogram (ECG) machine
though only 1 (33.3%) of these was functional. Ten
(76.9%) RRHs and 21 (80.8%) GHs had X-ray machines,
but just over half of these were functional (6; 60.0% and
11; 52.4%, respectively). Two (14.3%) HCIVs had X-ray
machines, but neither of them were functional. Even fewer
health facilities had other types of advanced equipment.
For example, 38.5% of RRHs had a Doppler machine and
15.4% had a CT-scan. Few health facilities reported having
a reliable power supply necessary to power these advanced
pieces of clinical equipment. Specifically, 53.9% of RRHs,
61.5% of GHs, and 28.6% of HCIVs reported having a reli-
able power supply. Although not always functional, 69.2%
of RRHs, 73.1% of GHs, and 64.3% of HCIVs had an alter-
native source of power which was usually a generator or
solar panels (Table 6).
Laboratory services
All of the RRHs and GHs (100%) and 12 of the
HCIVs (86%) had an on-site laboratory. In general,
RRHs had the highest proportion of facilities whose
laboratories offered general tests, such as hemoglobin,
complete blood count and differential, electrolytes,
renal function tests, liver function tests, lipid profile,
and urinalysis. The only laboratory test uniformly
available at all surveyed facilities was random blood
glucose. The ability to perform a HbA1c, an import-
ant test for diabetes monitoring, was limited to five
(19.2%) GHs and was unavailable in RRHs.
Hemoglobin electrophoresis, a fairly sophisticated test
that can be used for diagnosing sickle cell disease,
was also limited to GHs and unavailable in RRHs.
The availability of additional laboratory services are
shown in Table 7.
Essential medicines for NCDs
The standard protocol for assessing availability of essen-
tial medicines, according to SARA, is a visual spot-check
of dispensary shelves which we did not conduct. How-
ever, given that National Medical Stores (NMS) resup-
plies facilities with medicines every two months [15],
resulting in variability in medicine stock over time, we
attempted to gather information regarding trends in
medicine availability. Eleven (69%) RRHs, 15 GHs (58%),
and 9 HCIVs (64%) reported they routinely did not re-
ceive the drugs requested from NMS. Ten (77%) RRHs,
Table 3 Health facilities surveyed, by geographic category
Type of Facility Total
Surveyed
Geographic category
Urban n/Total respondents (%) Rural n/Total respondents (%)
Regional Referral Hospital (RRH) 13 8/9 (88.9) 1/9 (11.1)
General Hospital (GH) 26 6/21 (28.6) 15/21 (71.4)
Health Center IV (HCIV) 14 3/12 (25) 9/12 (75)
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17 (65%) GHs, and 10 HCIVs (71%) reported they rou-
tinely did not receive the requested quantity of particular
drugs. All facilities surveyed reported experiencing
stock-outs of at least one class of essential medicine for
NCDs within the previous year. Availability and
stock-outs of medicines used to treat hypertension and
diabetes are shown in Table 8.
Specialty NCD clinics
The most common type of subspecialty clinic type at the
sampled health facilities was a Diabetes Clinic. These
were available in 11 RRHs (84.6%) and 14 GHs (53.8%).
Although specialty clinics are not expected in Ugandan
HCIVs, 3/14 (21.4%) offered a Diabetes Clinic (Table 9).
Patient support and education
The range of activities offered at facilities were broad,
varying from printed handouts to more structured in
person support services. Individual NCD education -
one-on-one encounters between a health professional
and a patient to improve the patient’s understanding of
chronic disease (s) as well to create a self-management
plan - was offered at 9 (69.2%) RRHs and 17 (65.4%)
GHs, while group education was offered at 12 (92.3%)
RRHs and 18 (69.2%) GHs. Eight (61.5%) RRHs and 15
(57.7%) of GHs offered foot care for diabetic patients.
Nutritional advice was offered to patients at most facil-
ties, though only 4 (30.8%) RRHs, 2 (7.7%) GHs, and 2
(14.3%) of HCIVs provided NCD Information, Education
and Communication (IEC) materials, such as posters
Table 4 Health care personnel staffing, by health facility level
Personnel Type Regional Referral Hospitals (N = 13) General Hospitals (N = 26) Health Center IVs (N = 14)
No. reporting at least 1
staff member of this cadre
n (%)
Mean no. of
members
(±SD)
No. reporting at least 1
staff member of this cadre
n (%)
Mean no. of
members
(±SD)
No. reporting at least 1
staff member of this cadre
n (%)
Mean no. of
members
(±SD)
General Practitioners
Family physician 3 (23.1) 1.7 (± 1.2) 3 (11.5) 1.0 (± 0.0) 0 (0.0) –
Medical officer 10 (76.9) 5.3 (± 4.3) 23 (88.4) 3.4 (±1.9) 11 (78.6) 1.2 (±0.7)
Clinical officer 13 (100.0) 10.6 (± 3.9) 23 (88.4) 6.0 (±3.1) 11 (78.6) 1.2 (±1.3)
Specialist Physicians
Cardiologist 1 (7.7) 1.0 (± 0.0) 1 (3.8) 5.0 (± 0.0) 3 (21.4) 1.7 (±0.6)
Endocrinologist/
diabetologist
1 (7.7) 1.0 (± 0.0) 1 (3.8) 2.0 (± 0.0) 0 (0.0) –
Neurologist 0 (0.0) – 1 (3.8) 1.0 (± 0.0) 0 (0.0) –
Oncologist 0 (0.0) – 0 (0.0) – 0 (0.0) –
Pathologist 1 (7.7) 1.0 (± 0.0) 0 (0.0) – 0 (0.0) –
Psychiatrist 1 (7.7) 1.0 (± 0.0) 2 (7.7) 1.0 (± 0.0) 3 (21.4) 1.0 (± 0.0)
Pulmonologist 0 (0.0) – 0 (0.0) – 0 (0.0) –
Radiologist 6 (46.2) 1.8 (± 1.3) 0 (0.0) – 0 (0.0) –
Nurse
Nurse - general 10 (76.9) 47.8 (± 22.2) 22 (84.6) 33.2 (±15.8) 13 (92.9) 5.4 (±1.7)
Nurse - diabetic 4 (30.8) 3.0 (± 1.0) 7 (26.9) 1.4 (±0.8) 2 (14.3) 2.5 (±2.1)
Nurse -
psychiatric
9 (69.2) 3.9 (± 3.3) 20 (76.9) 1.6 (±0.9) 8 (57.1) 1.8 (±0.5)
Other
Community
health worker
7 (53.8) 2.6 (± 0.9) 7 (26.9) 5.3 (±6.6) 2 (14.3) 1.9 (± 2.1)
NCD Counselor 0 (0.0) – 1 (3.8) 2.0 (± 0.0) 0 (0.0) –
Foot care
specialist
1 (7.7) 1.0 (± 0.0) 0 (0.0) – 0 (0.0) –
Social worker 6 (46.2) 1.6 (± 0.9) 11 (42.3) 1.1 (±0.3) 0 (0.0) –
Diabetes
educator
1 (7.7) 1.0 (± 0.0) 1 (3.8) 6.0 (± 0.0) 0 (0.0) –
Nutritionist 8 (61.5) 1.3 (± 0.5) 8 (30.8) 1.1 (± 0.35) 0 (0.0) –
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and brochures. Ten (77.0%) RRHs offered
self-management NCD support and provided linkages to
peer/social group NCD support. Thirteen (50%) GHs
and 2 (14.3%) HCIVs offered self-management NCD
support and 10 (38.5%) and 3 (21.4%), respectively, pro-
vided linkages to peer/social group NCD support
(Table 10).
Quality assurance
WHO-PEN considers the use of patient registries and
management guidelines among the minimum quality
assurance standards for NCD care at health facilities.Er-
ror! Bookmark not defined. Most surveyed facilities
also did not track patients with NCDs by using regis-
tries. Only six (46.2%) RRHs were using such registries
for new NCD cases in at least one type of NCD clinic.
Only 4 (30.8%) RRHs, 4 (15.4%) GHs, and 1 (7.1%)
HCIVs reported having access to diabetes management
guidelines (Table 11). Even fewer reported having access
to guidelines on management of hypertension, hyperlip-
idemia, and asthma, and screening and treatment of to-
bacco use, cancer, mental health, or sickle cell disease.
Table 5 Availability of basic clinical equipment, by health facility level
Equipment No. of facilities (by type) that have at least one of equipment
RRH (N = 13) n (%) GH (N = 26) n (%) HCIV (N = 14) n (%)
Thermometer 7 (53.8) 14 (53.9) 8 (57.1)
Stethoscope 8 (61.5) 16 (61.5) 7 (50.0)
Blood pressure machine: Mercury sphygmomanometer 6 (46.2) 9 (34.6) 6 (42.9)
Blood pressure machine: Aneroid 6 (46.2) 7 (26.9) 6 (42.9)
Blood pressure machine: Automated 5 (38.5) 13 (50.0) 5 (35.7)
BP cuffs: Standard (25 cm × 12 cm) 4 (30.8) 9 (34.6) 8 (57.1)
BP cuffs: Alternate (36 cm × 12 cm) 0 (0.0) 1 (3.8) 1 (7.1)
BP cuffs: Pediatric 1 (7.7) 3 (11.5) 3 (21.4)
Measuring tapes 7 (53.8) 13 (50.0) 7 (50.0)
Weighing scales: Bathroom type 7 (53.8) 15 (57.7) 8 (57.1)
Weighing scales: Hospital type 4 (30.8) 11 (42.3) 4 (28.6)
Glucometer 8 (61.5) 19 (73.1) 6 (42.9)
Urine testing strips 3 (23.1) 2 (7.7) 2 (14.3)
Monofilament 1 (7.7) 1 (3.8) 0 (0.0)
Spirometer 1 (7.7) 0 (0.0) 0 (0.0)
Spacers for inhalers 3 (23.1) 1 (3.8) 1 (7.1)
Nebulizer 4 (30.8) 2 (7.7) 2 (14.3)
All of the above 0 (0.0) 0 (0.0) 0 (0.0)
None of the above 1 (7.7) 2 (7.7) 2 (14.3)
Table 6 Availability and function of advanced clinical equipment, by health facility level
Equipment Regional Referral Hospitals (N = 13) General Hospitals (N = 26) Health Center IVs (N = 14)
Available n (%) Functional n (%) Available n (%) Functional n (%) Available n (%) Functional n (%)
Ultrasound Scan 11 (84.6) 6 (54.6) 22 (84.6) 17 (77.3) 7 (50.0) 3 (42.9)
ECG Machine 3 (23.1) 1 (33.3) 4 (15.4) 2 (50.0) 1 (7.2) 0 (0.0)
X-Ray 10 (76.9) 6 (60.0) 21 (80.8) 11 (52.4) 2 (14.3) 0 (0.0)
CT-Scan 2 (15.4) 1 (50.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Doppler 5 (38.5) 3 (60.0) 1 (3.8) 0 (0.0) 0 (0.0) 0 (0.0)
Reliable power supply 7 (53.8) 4 (57.1) 16 (61.5) 13 (81.3) 4 (28.6) 2 (50.0)
Alternative source of power 9 (69.2) 7 (77.8) 19 (73.1) 17 (89.5) 9 (64.3) 4 (44.4)
All of the above 1 (7.7) 1 (7.7) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
None of the above 2 (15.4) 4 (30.8) 2 (7.7) 5 (19.2) 3 (21.4) 8 (57.1)
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Procurement and distribution
In July 2015, these data were utilized by MOH to guide
the distribution of newly acquired essential equipment
to the 53 surveyed health facilities. The procurement
and distribution included: HbA1c machines and sup-
plies, glucometers and glucose strips, weighing scales,
BP machines, tuning forks, reflex hammers, tape mea-
sures, stethoscopes, stadiometers, fundoscopes, and
monofilaments.
Discussion
Results of this assessment of the capacity of Ugandan
health facilities to address NCDs demonstrate areas of
strength as well as significant gaps in the availability of
equipment, medicines, and laboratory tests. Although
there is variability among the different types of health fa-
cilities, none of the facilities surveyed meet the
WHO-PEN standards for essential tools and medicines
to implement effective NCD interventions [10].
As expected, the RRHs largely fared better than
GHs and HCIVs, but a concerning number of facil-
ities lacked equipment, drugs, and standard guide-
lines for basic and effective NCD prevention and
control, based on the WHO-PEN. Particularly con-
cerning at these higher level facilities were the short-
comings in the supply of basic essential
technologies. Providers working at health facilities
lacking blood pressure machines, measuring tapes,
and scales cannot effectively risk-stratify their pa-
tients for cardiovascular disease. Without glucose
testing strips, providers cannot be expected to de-
liver adequate care for patients with diabetes.
In addition to basic technologies, all facilities expe-
rienced concerning numbers of essential NCD medi-
cines stockouts within the previous year. The recent
USAID-funded Securing Ugandans’ Right to Essential
Medicines (SURE) [16] is an example of promising
work focused on improving access to medicines in
the country. However, despite efforts such as SURE,
recent evidence demonstrates the continued short-
ages of, and disparities in, essential medicine avail-
ability in Uganda [9]. When medicines and basic
technologies are unavailable in the public sector, pa-
tients must procure these for themselves in the pri-
vate sector. However, despite generally better
availability, access for patients is still highly re-
stricted by cost. A recent study in Uganda found
that 27% of medicines and 32% of diagnostic tests
for diabetes and cardiovascular disease were afford-
able, based on a cost of less than or equal to three
days’ wages of a low-level government worker [17].
The importance of improving the supply chain for
NCD medicines deserves special mention particularly
given that medicine resupply from NMS occurs only
every two months. A reduction in stock-outs of
NCD medicines will not be achievable without im-
provements in their supply chain networks. The dis-
tribution network for NCD medicines is much less
refined than that of HIV medicines which are ac-
quired and distributed though donor-funded mecha-
nisms with sophisticated supply chains [18]. Lessons
learned from the successes of HIV supply chains and
can be applied to NCD supply chains with minimal
investment [19] .
There are a number of concerning features regarding
the presence of clinical equipment at the surveyed facil-
ities including high rates of non-functional equipment.
Ultrasound machines are often used in the diagnosis and
Table 7 Laboratory equipment and test availability, by health
facility level
On-site laboratory Number of facilities with laboratory
equipment or test
RRH (N = 13)
n (%)
GH (N = 26)
n (%)
HCIV (N = 14)
n (%)
13 (100%) 26 (100%) 12 (86%)
General tests
Hemoglobin 12 (92.3) 23 (88.5) 11 (78.6)
Complete blood count
and differential
11 (84.6) 19 (73.1) 5 (35.7)
Electrolytes 9 (69.2) 10 (38.5) 0 (0.0)
Renal function 9 (69.2) 13 (50.0) 1 (7.1)
Liver function 9 (69.2) 11 (42.3) 0 (0.0)
Lipid profile 6 (46.2) 8 (30.8) 1 (7.1)
Urinalysis 11 (84.6) 25 (96.2) 13 (92.9)
All of the above 6 (46.2) 6 (23.1) 0 (0.0)
None of the above 1 (7.7) 0 (0.0) 0 (0.0)
Diabetes tests
Random blood glucose 12 (92.3) 23 (88.5) 14 (100.0)
Hemoglobin A1c 0 (0.0) 5 (19.2) 0 (0.0)
Urine microalbumin 4 (30.8) 3 (11.5) 0 (0.0)
All of the above 0 (0.0) 1 (3.8) 0 (0.0)
None of the above 1 (7.7) 2 (7.7) 0 (0.0)
Cancer tests
Cytology 2 (15.4) 3 (11.5) 0 (0.0)
Fecal occult blood 3 (23.1) 4 (15.4) 0 (0.0)
Prostate-Specific Antigen 1 (7.7) 2 (7.7) 1 (7.1)
All of the above 0 (0.0) 0 (0.0) 0 (0.0)
None of the above 8 (61.5) 19 (73.1) 13 (92.9)
Sickle cell disease tests
Hemoglobin electrophoresis 0 (0.0) 4 (15.4) 0 (0.0)
Sickling test 11 (84.6) 21 (80.8) 7 (50.0)
All of the above 0 (0.0) 2 (7.7) 0 (0.0)
None of the above 2 (15.4) 4 (15.4) 7 (50.0)
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management of chronic kidney disease that is a common
outcome of diabetes and hypertension. X-rays are import-
ant tests in the management of lung diseases, both com-
municable (such as tuberculosis) and non-communicable
(such as COPD).
The 53 higher level public sector Ugandan health facil-
ities surveyed generally lacked basic NCD prevention
and screening services. Though community-based pre-
vention and screening activities are an important com-
ponent for the promotion of healthy lifestyles and early
detection of NCDs [20], health facilities play a vital role
in the continuum of services for patients. Despite this,
less than half of all health facilities have the essential
equipment and tests to screen for NCDs. Many of the
facilities do not conduct basic and necessary NCD ser-
vices, especially at the GH and HCIV level. This is espe-
cially concerning given the primary health care focus of
these facilities and the likelihood that these facilities see
the same patients more regularly than RRHs and there-
fore have more opportunity to prevent, identify, and
manage NCDs. One area of strength in our findings was
the availability of individual and group NCD education
and nutritional counseling, most of which were offered
at a majority of sampled facilities. In addition, 77% of
RRHs sampled offered peer NCD support groups. Effect-
ive NCD prevention efforts must be more robust and
Table 8 Availability of medicines for hypertension and diabetes, by health facility level
Pharmaceutical
Classes
RRH (N = 13) GH (N = 26) HCIV (N = 14)
No. that have
drug available
Stockout in
last quarter
Stockout
in last
year
No. that have
drug available
Stockout in
last quarter
Stockout
in last
year
No. that have
drug available
Stockout in
last quarter
Stockout
in last
year
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Hypertension
Thiazide diuretic 12 (92.3) 1 (7.7) 2 (15.4) 23 (88.5) 3 (11.5) 2 (7.7) 9 (64.3) 3 (21.4) 2 (14.3)
Calcium channel
blocker
12 (92.3) 1 (7.7) 1 (7.7) 22 (84.6) 2 (7.7) 3 (11.5) 14 (100.0) 4 (28.6) 5 (35.7)
Beta-blocker 7 (53.8) 3 (23.1) 3 (23.1) 14 (53.8) 9 (34.6) 7 (26.9) 13 (92.9) 3 (21.4) 3 (21.4)
ACE inhibitor 10 (76.9) 2 (15.4) 2 (15.4) 20 (76.9) 5 (19.2) 6 (23.1) 6 (42.9) 2 (14.3) 2 (14.3)
Others (e.g.
Methyldopa,
hydralazine,
magnesium
sulphate)
10 (76.9) 2 (15.4) 2 (15.4) 20 (76.9) 2 (7.7) 5 (19.2) 9 (64.3) 3 (21.4) 2 (14.3)
Diabetes
Biguanides 12 (92.3) 0 (0.0) 0 (0.0) 23 (88.5) 4 (15.4) 2 (7.7) 14 (100.0) 4 (28.6) 5 (35.7)
Sulfonylureas 11 (84.6) 2 (15.4) 2 (15.4) 21 (80.8) 6 (23.1) 2 (7.7) 11 (78.6) 3 (21.4) 4 (28.6)
Thiazolidinediones 1 (7.7) 2 (15.4) 2 (15.4) 2 (7.7) 5 (19.2) 4 (15.4) 1 (7.1) 1 (7.1) 1 (7.1)
Dipeptidyl
peptidase-4
inhibitors
1 (7.7) 1 (7.7) 1 (3.8) 5 (19.2) 4 (15.4) 1 (7.1) 1 (7.1) 0 (0.0)
Alpha-glucosidase
inhibitors
1 (7.7) 1 (7.7) 2 (7.7) 5 (19.2) 5 (19.2) 0 (0.0) 0 (0.0) 1 (7.1)
Insulin
type
Ultra short-
acting
8 (61.5) 1 (7.7) 0 (0.0) 9 (34.6) 3 (11.5) 6 (23.1) 3 (21.4) 0 (0.0) 0 (0.0)
Short-acting 9 (69.2) 3 (23.1) 3 (23.1) 14 (53.8) 2 (7.7) 6 (23.1) 5 (35.7) 1 (7.1) 1 (7.1)
Intermediate 10 (76.9) 3 (23.1) 5 (38.5) 12 (46.2) 4 (15.4) 6 (23.1) 3 (21.4) 0 (0.0) 0 (0.0)
Long-acting 11 (84.6) 3 (23.1) 4 (30.8) 14 (53.8) 3 (11.5) 5 (19.2) 3 (21.4) 1 (7.1) 1 (7.1)
Table 9 Sub-specialty NCD clinics, by health facility level
Clinics/Wards RRH (N = 13) n
(%)
GH (N = 26) n
(%)
HCIV (N = 14) n
(%)
Diabetes 11 (84.6) 14 (53.8) 3 (21.4)
Hypertension 7 (53.9) 5 (19.2) 1 (7.1)
Cancer 2 (15.4) 1 (3.8) 0 (0.0)
Cardiology 2 (15.4) 1 (3.8) 0 (0.0)
COPD 1 (7.7) 0 (0.0) 0 (0.0)
Renal 2 (15.4) 0 (0.0) 0 (0.0)
Sickle Cell 4 (30.8) 2 (7.7) 0 (0.0)
All of the above 0 (0.0) 0 (0.0) 0 (0.0)
None of the
above
1 (7.7) 11 (42.3) 11 (78.6)
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multi-faceted. These should include proven
population-level strategies, such as the WHO Best Buys
[21], public health awareness campaigs using mass/social
media, and community empowerment efforts such as at
schools and places of work [22]. But public health cam-
paigns must also be accompanied by individual-level
health promotion efforts. At the individual patient level,
health promotion education can take many forms [23].
This includes Information, Education, and Communica-
tion (IEC) materials, which were offered at only 14.3% of
HCIVs and 7.7% of GHs in our study but could also in-
clude innovative self-management tools such as illus-
trated booklets [24] and mobile health platforms that
might be leveraged to include NCD-related educational
content. Alcohol and tobacco screening was reported to
occur in only a small fraction of sampled facilities but
these are critical elements of NCD prevention that can
easily be performed by healthcare providers and are
proven effective [25, 26].
The health facilities in our study also had poor quality
assurance methods in place for NCD services. Only 11.5
and 15.4% of GHs in our study utilized diabetes and
hypertension guidelines, respectively. A similar study in
Tanzania found that 13% of facilities used guidelines for
these conditions [27]. Algorithmic approaches to chronic
disease management are especially critical in lower-level
facilities in which care is provided by non-medical-doctor
clinicians. Integrated approaches to comprehensive NCD
care, such as WHO HEARTS, which was developed based
on WHO-PEN, must incorporate management algorithms
that can be easily followed and are locally appropriate and
rational for the setting.
This study also highlights the urgent need for tools
to allow countries like Uganda to frequently measure
and monitor the availability of health service delivery
indicators. SARA, an extensive and robust
WHO-endorsed survey tool, is meant to be conducted
annually. However, the most recent SARA in Uganda
was completed in 2014. Such infrequent assessments
of health system readiness and service availability cre-
ate major challenges to the proper planning and ef-
fective distribution of limited resources. Health
systems face many competing priorities. Not all NCDs
are of equal burden and, therefore, not all essential
services can, nor should necessarily, be distributed
equally. An example in Uganda would be hyperten-
sion, which has a prevalence of 26.4% [28] compared
to diabetes which has a prevalence of 1.4% [3].This is
the basis for WHO-PEN, which itself represents a
core set of low-cost, high-impact NCD interventions
that can be delivered through a primary care ap-
proach [29].
Given that there were three SARA surveys con-
ducted in Uganda between 2012 and 2014, we feel it
is important to point out a number of specific ways
in which our study adds to the evidence available
from those surveys. The 2014 SARA survey was the
most similar to our survey in terms of health facilities
sampled insofar as it was restricted to HCIV and
above. This SARA survey, like our study, inquired
about functionality of equipment during the deploy-
ment of the survey However, the NCD-related con-
tent of this survey was limited to the availability of a
few basic pieces of equipment (ie blood pressure ma-
chine and stethoscope) and 20 essential medicines.
The 2012 and 2013 SARA surveys sampled a wider
array of facility types but also were more comprehen-
sive in terms of NCD-related scope. Our assessment
of service availability included the presence of many
Table 10 NCD education and support, by health facility level
Education or support service RRH (N =
13) n (%)
GH (N =
26) n (%)
HCIV (N =
14) n (%)
Individual NCD education 9 (69.2) 17 (65.4) 5 (35.7)
Group NCD education 12 (92.3) 18 (69.2) 4 (28.6)
Foot care for diabetic patients 8 (61.5) 15 (57.7) 2 (14.3)
Nutrition advice for all patients 12 (92.3) 23 (88.5) 11 (78.6)
NCD Information, Education and
Communication (IEC) materials
4 (30.8) 2 (7.7) 2 (14.3)
Self-management NCD support 10 (77.0) 13 (50.0) 2 (14.3)
Peer/social group NCD support 10 (77.0) 10 (38.5) 3 (21.4)
All of the above 2 (15.4) 2 (7.7) 0 (0.0)
None of the above 1 (7.7) 1 (3.8) 1 (7.1)
Table 11 Availability of NCD guidelines, by health facility level
Registries and Guidelines RRHs N =
13 n (%)
GHs N =
26 n (%)
HCIVs N =
14 n (%)
NCD registry for new cases 6 (46.2) 6 (23.1) 1 (7.1)
Diabetes management 4 (30.8) 4 (15.4) 1 (7.1)
Hypertension management 3 (23.1) 3 (11.5) 1 (7.1)
Hyperlipidemia management 0 (0.0) 2 (7.7) 0 (0.0)
Tobacco screening & treatment 0 (0.0) 2 (7.7) 0 (0.0)
Alcohol screening & treatment 0 (0.0) 1 (3.9) 1 (7.1)
Cancer (cervical, breast, prostate)
screening & treatment
3 (23.1) 2 (7.7) 2 (14.3)
Mental health screening &
treatment
2 (15.4) 3 (11.5) 2 (14.3)
Asthma management 2 (15.4) 2 (7.7) 1 (7.1)
Sickle cell screening &
management
2 (15.4) 3 (11.5) 0 (0.0)
Palliative care 2 (15.4) 6 (23.1) 1 (7.1)
All of the above 0 (0.0) 0 (0.0) 0 (0.0)
None of the above 4 (30.8) 13 (50.0) 10 (71.4)
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types of personnel, including nutritionists, social
workers, and diabetes nurses, among others, and
assessed confidence. Comprehensive NCD care re-
quires a team-based approach and continuing educa-
tion to build confidence and this is not assessed in
SARA. SARA assesses medicine availability by spot--
checking on pharmacy shelves, while we assessed re-
ported trends in medicine availability over time by
inquiring about stock-outs. While neither method-
ology adequately substitutes for real-time monitoring
of availability, we feel these two techniques comple-
ment one another and could both be employed in
future work. The 2013 SARA reported 80% availabil-
ity of CVD guidelines, while we found markedly
lower availability of these, as discussed earlier. This
is illuminating and we feel is related to methodology.
While SARA spot-checks for availability of guidelines
at facilities, the fact that we asked clinical leaders
about the presence of guidelines was likely more in-
dicative of the likelihood that they are actually being
used in clinical practice. NCD care requires tools,
such as ECG, that are considered by WHO-PEN to
be advanced technologies. SARA does not survey for
these items. Not only was ECG available in a minor-
ity of sampled facilities, but in only 5.6% of all sam-
pled facilities was ECG functional. Future nationally
representative assessments of health facility capacity
to address NCDs might be bolstered by incorporat-
ing some of the methodologies employed by our
study.
The local dissemination of our findings led to a
guided procurement and distribution process, as de-
scribed above. Though the number of each of these
items was modest, this represents an important ap-
propriation of essential tools by MOH based on the
findings of this survey. Documentation of system gaps
should always be met by attempts to close those gaps.
We believe that the alignment of this needs assess-
ment with MOH priorities and the strategic dissemin-
ation process likely aided this process and should
serve as a model to other researchers aiming to docu-
ment health system deficiencies.
This study has a number of limitations. First, the study
sample was not randomly selected and did not include
all of the GHs or HCIVs. Consequently, the results from
this needs assessment may not be fully representative.
Second, the “gold standard” of conducting a needs as-
sessment is time-intensive direct observation [12]. How-
ever, due to time and funding constraints, each survey
was completed in less than one day and the quality and
accuracy of the data collected depended on the staff
available on the particular day of the study team visit.
The levels of knowledge and experience of personnel
who helped to complete the survey varied at each facility
which may have affected the accuracy of reports. There-
fore, future improvements for similar needs assessment
surveys would include randomized sampling, standard-
ized data collection methods [30], and time-intensive
direct observation with manual spot checks. A more sus-
tainable alternative, though one with substantial associ-
ated up-front costs, would be digitization of supply
chain management which would allow for improved
transparency and data access by individuals within facil-
ities and in health sector planning positions. Finally, in
some cases, we observed unexpectedly lower propor-
tions of available essential medicines and technologies in
RRHs than in GHs. In our experience, there were likely
two explanations for this finding. First, some GHs re-
ceive donations from non-governmental organizations
rendering them better equipped than their counterparts.
Second, facilities differ in their organizational structures
and administrative management. Those that are more
organized and better managed are likely to be better
equipped. Recent analyses of Ugandan SARA data also
revealed that some GHs were better supplied than some
RRHs [Error! Bookmark not defined.]. Despite these
limitations, this needs assessment provided data and in-
formation about Ugandan health facilities that was previ-
ously unknown and can be considered complementary
to other sources of facility readiness data.
Conclusions
This first nationwide research study of the capacity of
higher level public sector health facilities in Uganda to
provide NCD services highlights many critical gaps.
These gaps were addressed, to a limited extent, throught
the resulting procurement and distribution process.
However, deficiencies such as those of healthcare
personnel quantity and training, and access to medi-
cines will continue to limit the potential for improving
the quality of NCD service delivery in the country. This
study demonstrates the need for Uganda to scale-up
low cost, high impact NCD interventions and
strengthen the capacity of health personnel to reduce
NCD-related disability and death. Improvement of the
capacity of health facilities and personnel to effectively
detect and manage NCDs can yield significant eco-
nomic gain for Uganda through a reduction in prema-
ture mortality, improved quality of life, and increased
productivity [11]. Finally, as the world prepares for the
third United Nations General Assembly high-level
meeting on NCDs later this year, it is imperative to
state that any system changes that seek to fill gaps such
as those identified in this study must come in the con-
text of attention to equitable distribution of resources
and attention to the socioecomonic determinants of
health [21].
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Appendix
Table 12 Description of participants in July 26, 2013 review meeting in Kampala, Uganda
Organization/Institution (n) Description of participants (n)
Ministry of Health (6) Technical staff from:
Health promotion (1)
Non-communicable disease program (5)
Mulago National Referral Hospital (7) Physician consultants (5)
Pediatric endocrinologist (1)
Medical officer (1)
Departments represented include cardiology, oncology, endocrinology, pulmonology, and general medicine
Regional referral hospitals (12) Directors, who are also physicians and surgeons (5)
Physicians (6)
Medical officer (1)
World Health Organization-Uganda (1) NCD officer (1)
Uganda NCD Alliance (3) Physicians (2)
Coordinator (1)
Table 13 List of health facilities surveyed
Regional Referral Hospitals (n = 13) General Hospitals (n = 26) Health Center IVs (n = 14)
Arua RRH Apac Hospital Alebtong HCIV
Fort Portal RRH Kaabong Hospital Amuria HCIV
Gulu RRH Tororo Hospital Budaka HCIV
Hoima RRH Anaka Hospital Dokolo HCIV
Jinja RRH Fort Portal RRH Kabwohe HCIV
Kabale RRH Kisoro Hospital Kamukira HCIV
Lira RRH Lyantonde Hospital Kassanda HCIV
Masaka RRH Bundibugyo Hospital Kebisoni HCIV
Mbale RRH Itojo Hospital Koboko HCIV
Mbarara RRH Rakai Hospital Nabilatuk HCIV
Moroto RRH Kyenjojo General Hosp. Padibe HCIV
Mubende RRH Abim Hospital Rwekubo HCIV
Soroti RRH Kagadi Hospital Sembabule HCIV
Bwera General Hospital
Moyo Hospital
Iganga Hospital
Rushere Hospital
Pallisa Hospital
Nebbi General Hospital
Atutur Hospital
Masindi Hospital
Kiboga Hospital
Kiryandongo Hospital
Kitgum Hospital
Bugiri Hospital
Bududa Hospital
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Additional file 1: MOH Needs Assessment Tool. Non-Communicable
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